Dynamic Technology Lab Private Ltd Takes Position in DENTSPLY SIRONA Inc. $XRAY

Dynamic Technology Lab Private Ltd purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 63,397 shares of the medical instruments supplier’s stock, valued at approximately $805,000.

Other hedge funds have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in DENTSPLY SIRONA during the 1st quarter worth about $26,000. Parkside Financial Bank & Trust raised its stake in shares of DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,477 shares during the last quarter. Huntington National Bank lifted its position in shares of DENTSPLY SIRONA by 292.9% during the third quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 2,077 shares in the last quarter. True Wealth Design LLC grew its stake in shares of DENTSPLY SIRONA by 49.7% during the third quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock valued at $45,000 after purchasing an additional 1,181 shares during the last quarter. Finally, Central Pacific Bank Trust Division grew its stake in shares of DENTSPLY SIRONA by 100.0% during the third quarter. Central Pacific Bank Trust Division now owns 4,000 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 2,000 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several research analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, January 21st. Mizuho increased their price objective on DENTSPLY SIRONA from $14.00 to $16.00 and gave the company a “neutral” rating in a research report on Monday, March 2nd. Bank of America upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $13.00 to $17.00 in a research report on Thursday, February 19th. Zacks Research raised DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research note on Monday, March 2nd. Finally, Barclays started coverage on DENTSPLY SIRONA in a report on Monday, December 8th. They issued an “underweight” rating and a $12.00 price target on the stock. Three research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $14.42.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $12.80 on Tuesday. The firm’s 50 day moving average price is $12.66 and its two-hundred day moving average price is $12.44. The company has a debt-to-equity ratio of 1.50, a quick ratio of 1.03 and a current ratio of 1.51. DENTSPLY SIRONA Inc. has a 52-week low of $9.85 and a 52-week high of $17.18. The stock has a market cap of $2.56 billion, a PE ratio of -4.27, a PEG ratio of 1.49 and a beta of 0.97.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). The business had revenue of $961.00 million for the quarter, compared to the consensus estimate of $926.40 million. DENTSPLY SIRONA had a negative net margin of 16.25% and a positive return on equity of 18.85%. The business’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.26 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio is currently -21.33%.

Insider Activity

In related news, Director James D. Forbes purchased 5,000 shares of the stock in a transaction dated Monday, March 9th. The stock was bought at an average cost of $12.48 per share, with a total value of $62,400.00. Following the purchase, the director directly owned 10,000 shares in the company, valued at $124,800. The trade was a 100.00% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Gregory T. Lucier purchased 27,555 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was purchased at an average price of $14.24 per share, for a total transaction of $392,383.20. Following the completion of the transaction, the director directly owned 27,555 shares in the company, valued at $392,383.20. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 70,000 shares of company stock worth $956,437 in the last three months. Insiders own 0.52% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.